Discover
CLRB
Cellectar Biosciences, Inc.
1.45
2 x 1.29
10 x 12.00
bid
ask
+
0.05
3.57%
6 @ 04:00 PM
1.45 +0.00 (0.00%)
| Ytd | -50.85% | |
| 1y | -69.60% |
1.37
day range
1.49
1.40
52 week range
4.98
| Open | 1.41 | Prev Close | 1.40 | Low | 1.37 | High | 1.49 | Mkt Cap | 13.71M |
| Vol | 91.48K | Avg Vol | 63.86K | EPS | -3.57 | P/E | N/A | Forward P/E | -0.10 |
| Beta | 1.01 | Short Ratio | 8.34 | Inst. Own | 34.55% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 2.31 | 200-d Avg | 2.79 | 1yr Est | 5.67 |
| Income Statement | |||
| Operating Expenses | 7.20M | ||
| Research and Development Expense | 4.56M | ||
| Selling, General and Administrative Expense | 2.64M | ||
| Operating Income | -7.20M | ||
| Net Income | -6.93M | ||
| Net Income Common Stock | -6.93M | ||
| Net Income Common Stock (USD) | -6.93M | ||
| Consolidated Income | -6.93M | ||
| Earnings per Basic Share | -0.57 | ||
| Earnings per Basic Share (USD) | -0.57 | ||
| Earnings per Diluted Share | -0.57 | ||
| Earning Before Interest & Taxes (EBIT) | -6.93M | ||
| Earning Before Interest & Taxes (USD) | -6.93M | ||
| Weighted Average Shares | 12.23M | ||
| Weighted Average Shares Diluted | 12.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 33.99M | ||
| Cash and Equivalents (USD) | 33.99M | ||
| Current Assets | 34.88M | ||
| Property, Plant & Equipment Net | 1.74M | ||
| Total Assets | 36.64M | ||
| Debt Current | 2.03K | ||
| Total Debt | 1.53M | ||
| Current Liabilities | 5.24M | ||
| Debt Non-Current | 1.53M | ||
| Total Liabilities | 6.77M | ||
| Accumulated Retained Earnings (Deficit) | -281.72M | ||
| Shareholders Equity | 29.87M | ||
| Shareholders Equity (USD) | 29.87M | ||
| Assets Non-Current | 1.76M | ||
| Total Debt (USD) | 1.53M | ||
| Liabilities Non-Current | 1.53M | ||
| Trade and Non-Trade Payables | 5.22M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 35.52K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 25.65M | ||
| Net Cash Flow from Operations | -6.01M | ||
| Share Based Compensation | 428.31K | ||